Tuberculosis Cases Related to Tertiary Care Cardiac Center Experiences in the Last 10 Years

被引:0
作者
Kaya, Sibel Dogan [1 ]
Evik, Guliz [2 ]
Deniz, Munire [3 ]
机构
[1] Mersin Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Mersin, Turkiye
[2] Mersin Univ, Sch Med, Dept Infect Dis, Mersin, Turkiye
[3] Univ Hlth Sci, Kartal Kosuyolu Training & Res Hosp, Dept Anesthesiol & Reanimat, Istanbul, Turkiye
关键词
Drug resistant; Mycobacterium tuberculosis; organ transplantation; UNITED-STATES; OLDER-ADULTS; RISK-FACTORS; PREVENTION; EPIDEMIC;
D O I
10.4103/ijmy.ijmy_100_23
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background:Tuberculosis (TB) is one of the oldest and deadliest infectious diseases known to affect human health, which is gaining renewed importance today.Methods:In our center, which is a tertiary research hospital, the data of patients hospitalized due to TB between 2011 and 2022 were retrospectively identified by searching the database.Results:Six women (30.0%) and 14 men (70.0%) were included in the study. When analyzed by age grouping, four patients between the ages of 19 and 34 years (20.0%), five patients between the ages of 38 and 58 years (25.0%), five patients aged 61-69 years (25.0%), and six patients aged 70-81 years (30.0%). Radiographs showed cavitation in 9 (45.0%) patients, and 11 (55.0%) patients had no radiologic findings. The ARS results of the participants showed that there were 7 (35.0%) patients positive and 13 (65.0%) patients negative. When the TB culture variables of the participants were analyzed, it was found that there were 5 (25.0%) people with no growth and 15 (75.0%) people with growth. Concurrent diseases were noted in patients including 5 (25.0%) with organ transplantation, 3 (15.0%) with diabetes mellitus, 2 (%10) with cancer, and 2 (10%) with chronic renal failure according to the chart records. The distribution of cases was as follows: 19 (95.0%) pulmonary TB and 1 (5.0%) pleural TB. It was found that there were 5 (25.0%) people with a history of TBC and 15 people (75.0%) without a history of TBC. Moreover, drug susceptibility tests showed that 5 (25%) patients of the isolates were identified as multidrug resistant with first-line drug susceptibility testing.Conclusion:The study was not financially supported by any individual/organization, and the authors have no vested interests.
引用
收藏
页码:416 / 419
页数:4
相关论文
共 28 条
[1]   Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain [J].
Aguado, JM ;
Herrero, JA ;
Gavalda, J ;
TorreCisneros, J ;
Blanes, M ;
Rufi, G ;
Moreno, A ;
Gurgui, M ;
Hayek, M ;
Lumbreras, C ;
Morales, JM ;
Pahissa, A ;
Margerit, C ;
Prada, JL ;
Kindelan, JM ;
Ros, F ;
Pallardo, LM ;
Carratala, J ;
Gudiol, F ;
Gonzalez, J ;
Vilardell, J ;
Guirado, L ;
Rabella, N .
TRANSPLANTATION, 1997, 63 (09) :1278-1286
[2]   Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis [J].
Al-Rifai, Rami H. ;
Pearson, Fiona ;
Critchley, Julia A. ;
Abu-Raddad, Laith J. .
PLOS ONE, 2017, 12 (11)
[3]  
[Anonymous], 2019, Extrapulmonary Tuberculosis, P97
[4]  
[Anonymous], 2022, Global Tuberculosis Report 2022, V1st
[5]  
Chan-Yeung M, 2006, INT J TUBERC LUNG D, V10, P892
[6]  
Chawla K, 2009, J INFECT DEV COUNTR, V3, P83
[7]   What We Know About Tuberculosis Transmission: An Overview [J].
Churchyard, Gavin ;
Kim, Peter ;
Shah, N. Sarita ;
Rustomjee, Roxana ;
Gandhi, Neel ;
Mathema, Barun ;
Dowdy, David ;
Kasmar, Anne ;
Cardenas, Vicky .
JOURNAL OF INFECTIOUS DISEASES, 2017, 216 :S629-S635
[8]   Tuberculosis - A global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage [J].
Couvin, David ;
Rastogi, Nalin .
TUBERCULOSIS, 2015, 95 :S177-S189
[9]  
DROMER C, 1993, J HEART LUNG TRANSPL, V12, P924
[10]   The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era [J].
Floyd, Katherine ;
Glaziou, Philippe ;
Zumla, Alimuddin ;
Raviglione, Mario .
LANCET RESPIRATORY MEDICINE, 2018, 6 (04) :299-314